---
document_datetime: 2026-02-12 09:55:36
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/kapruvia-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: kapruvia-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 2.8851677
conversion_datetime: 2026-02-13 18:59:25.057297
docling_version:
  docling-serve: 1.12.0
  docling-jobkit: 1.10.2
  docling: 2.73.1
  docling-core: 2.65.1
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Kapruvia

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0010/G            | This was an application for a group of variations. | 20/03/2025                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data   |            |            |      |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------|
| PSUSA/10995 /202408 | Periodic Safety Update EU Single assessment - difelikefalin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 13/03/2025 | n/a        |      | PRAC Recommendation - maintenance |
| PSUSA/10995 /202402 | Periodic Safety Update EU Single assessment - difelikefalin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 03/10/2024 | n/a        |      | PRAC Recommendation - maintenance |
| IB/0008             | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                              | 25/07/2024 | 27/06/2025 | SmPC |                                   |
| PSUSA/10995 /202308 | Periodic Safety Update EU Single assessment - difelikefalin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 07/03/2024 | n/a        |      | PRAC Recommendation - maintenance |
| IA/0006             | A.4 - Administrative change - Change in the name                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 27/02/2024 | n/a        |      |                                   |

<div style=\"page-break-after: always\"></div>

|                     | and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient   |            |            |                                  |                                                                                                            |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------|
| PSUSA/10995 /202302 | Periodic Safety Update EU Single assessment - difelikefalin                                                                                                                                   | 28/09/2023 | n/a        |                                  | PRAC Recommendation - maintenance                                                                          |
| PSUSA/10995 /202208 | Periodic Safety Update EU Single assessment - difelikefalin                                                                                                                                   | 16/03/2023 | n/a        |                                  | PRAC Recommendation - maintenance                                                                          |
| IB/0002             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                 | 21/09/2022 | n/a        |                                  |                                                                                                            |
| IB/0001             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                | 22/07/2022 | 17/07/2023 | SmPC, Annex II, Labelling and PL | To implement editorial changes in sections 4.8, 5.1 and 5.2 of the SmPC, annex II and section 3 of the PL. |